This content is machine translated Dementia Still forgetful or already demented? Effective treatment from the beginning The first signs of dementia are often not recognized, because the changes in the brain occur gradually. Often, a depressive episode also masks the actual symptoms. However, in order to…
View Post 4 min This content is machine translated Epilepsy Modern treatment management focuses on monotherapy The range of therapies for generalized and especially focal epilepsies is constantly expanding, so that the treatment regime can now be individually adapted to the needs of those affected. However,…
View Post 3 min This content is machine translated Parkinson's disease What is still possible when seemingly nothing else works Contemporary Parkinson’s therapy is multidisciplinary and is based on the individual needs of the patient. The experts at the dgp-Congress agreed. Increasing understanding of disease progression will enable personalized treatment,…
View Post 10 min This content is machine translated Sponsored Content: 5q-associated spinal muscular atrophy (5q-SMA). Nusinersen: Central to CNS, targeted effect. The antisense oligonucleotide nusinersen was approved in 2017 as the first drug for the causal treatment of patients with 5q-associated spinal muscular atrophy (5q-SMA) [1]. The drug targets the cause…
View Post 3 min This content is machine translated Multiple sclerosis Diagnosis, differential diagnosis and treatment up to date Depending on its course, multiple sclerosis can lead to rapid losses in quality of life. Research is working at full speed to further detect the pathology of the disease and…
View Post 4 min This content is machine translated Multiple sclerosis MS therapy: updated guideline and further updates at a glance The range of disease-modifying therapies (DMTs) for MS patients has expanded steadily in recent years. This has also been incorporated into the new edition of the DGN guideline. The benefits…
View Post 6 min This content is machine translated The Parkinson therapy in the very old Age does not make it better Although old age is not typical for PD and there are also young patients, the disease has always been associated with elderly people. Sufferers also often have to contend with…
View Post 5 min This content is machine translated Syndromes of vertigo Not only the domain of physical therapy With a lifetime prevalence of up to 30%, dizziness is a very common leading symptom in consultations with a wide range of disciplines, from ENT specialists to general practitioners and…
View Post 8 min This content is machine translated Parkinson's disease Clear reduction of motor fluctuations due to opicapone Many Parkinson’s patients experience motor fluctuations after several years of therapy. The duration of these uncontrollable fluctuations in mobility can be significantly reduced by adjuvant therapy with the COMT inhibitor…
View Post 4 min This content is machine translated Dementia Research Synergistic effects of ginkgo biloba extract and donepezil The efficacy of Ginkgo biloba extract and donepezil in promoting cognitive performance has been empirically demonstrated. Individual studies also support the hypothesis that an additional benefit can be achieved through…
View Post 4 min This content is machine translated CGRP antibodies for migraine prophylaxis Reduce the hammering in the head CGRP* antibodies for the prevention of migraine attacks, which have been approved since 2018, offer affected patients the possibility of a reduction in their headache days. Erenumab was the first…
